References
- Mountain C. F. Revisions in the international system for staging lung cancer. Chest, 1997, 111: 1710–7.
- Nesbitt J. C., Putnam J. B., Walsh G. L., Roth J. A., Mountain C. F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg, 1995, 60: 466–72.
- Choi Y. S., Shim Y. M., Kim S. H. et al. Prognostic significance of E-cadherin and ß-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg, 2003, 24: 441–9.
- Sakao Y., Tomimitsu S., Takeda Y., Natsuaki M., Itoh T. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg, 2004, 25: 520–2.
- D’amico T. A., Massey M., Herndon J. E., Moore M. B., Harpole D. H. A biological risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with ten molecular markers. J Thorac Cardiovasc Surg, 1999, 117: 736–43.
- Volk T., Geiger B., Raz A. Motility and adhesive properties of high-and low-metastatic murine neoplastic cells. Cancer Res, 1984, 44: 811–24.
- Evans C. P., Walsh D. S., Kohn E. C. An autocrine motility factor secretes by the Dunning R-3327 rat prostatic adenocarcinoma cell sub-type AT2.1 Int J Cancer, 1991, 49: 109–13.
- Rozen E. M., Goldberg I. D. Protein factors which regulate cell motility. In Vitro CellDevBiol, 1989, 25: 1079–87.
- Watanabe H., Carmi P., Hogan v. et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem, 1991, 266: 13442–8.
- Watanabe H., Shinozaki T., Raz A., Chigira M. Expression of autocrine motility factor receptor in serum-and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Int J Cancer, 1993, 53: 689–95.
- Maruyama K., Watanabe H., Shiozaki H. et al. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int J Cancer, 1995, 64: 316–21.
- Hirono Y., Fushida A., Yonemura Y., Yamamoto H., Watanabe H., Raz A. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer, 1996, 74 :, 2003–7.
- Kara M., Ohta A., Tanaka Y., Oda M., Watanabe Y. Autocrine motility factor receptor expression in patients with stage i non-small cell lung cancer. Ann Thorac Surg, 2001, 71: 944–8.
- Otto T., Birchmeier W., Schmidt U. et al. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res, 1994, 54: 3120–3.
- Nakamori S., Watanabe H., Kameyama M. et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer, 1994, 74: 1855–62.
- Travis W. D., Colby T. v., Corrin B., Shimosato Y., Brambilla E. Histological Typing of Pleural Tumours. 3rd ed. Berlin: SpringerVerlag, 1999.
- Nabi I. R., Watanabe H., Raz A. Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res, 1990, 50: 409–14.
- Siletti S., Watanabe H., Hogan v., Nabi I. R., Raz A. Purification of B16-F1 melanoma autocrine motility-like factor and its receptor. Cancer Res, 1991, 51: 3507–11.
- Takanami I., Takeuchi K, Watanabe H., Yanagawa H., Takagishi K., Raz A. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer. Int J Cancer, 2001, 20: 384–7.
- Sayar A., Turna A., Solak O., Kilicgun A., Urer N., Gurses A. Nonanatomic prognostic factors in resected non-small cell lung carcinoma: the importance of perineural invasion as a new prognostic marker. Ann Thorac Surg, 2004, 77: 421–5.